ArticleCurrent oncology (Toronto, Ont.)2014

Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensus.

S Couban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.